Expert Interview
Discussing Exelixis' Zanzalintinib + Atezolizumab (STELLAR-303) Phase 3 Results in Metastatic Colorectal Cancer: OS Benefit and Clinical Implications
Ticker(s): EXELInstitution: Odette Cancer Centre
- Medical Oncologist and Assistant Professor of Medicine at the University of Toronto
- Sees over 30+ patients for colorectal cancer
- Research Focus in Health care services and Neuroendocrine head and neck malignancies
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
